These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 12953964)
1. Clinical and laboratory features of dengue virus-infected travellers previously vaccinated against yellow fever. Teichmann D; Göbels K; Niedrig M; Grobusch MP Scand J Infect Dis; 2003; 35(6-7):427-9. PubMed ID: 12953964 [TBL] [Abstract][Full Text] [Related]
2. Yellow fever (YF) vaccination does not increase dengue severity: A retrospective study based on 11,448 dengue notifications in a YF and dengue endemic region. Luppe MJ; Verro AT; Barbosa AS; Nogueira ML; Undurraga EA; da Silva NS Travel Med Infect Dis; 2019; 30():25-31. PubMed ID: 31075425 [TBL] [Abstract][Full Text] [Related]
3. Emerging viral pathogens in long-term expatriates (II): Dengue virus. Jänisch T; Preiser W; Berger A; Niedrig M; Mikulicz U; Thoma B; Doerr HW Trop Med Int Health; 1997 Oct; 2(10):934-40. PubMed ID: 9357483 [TBL] [Abstract][Full Text] [Related]
4. Dengue virus infection in travellers returning to Berlin, Germany: clinical, laboratory, and diagnostic aspects. Teichmann D; Göbels K; Niedrig M; Grobusch MP Acta Trop; 2004 Mar; 90(1):87-95. PubMed ID: 14739027 [TBL] [Abstract][Full Text] [Related]
5. Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes. Guirakhoo F; Kitchener S; Morrison D; Forrat R; McCarthy K; Nichols R; Yoksan S; Duan X; Ermak TH; Kanesa-Thasan N; Bedford P; Lang J; Quentin-Millet MJ; Monath TP Hum Vaccin; 2006; 2(2):60-7. PubMed ID: 17012873 [TBL] [Abstract][Full Text] [Related]
6. Dengue-2 and yellow fever 17DD viruses infect human dendritic cells, resulting in an induction of activation markers, cytokines and chemokines and secretion of different TNF-α and IFN-α profiles. Gandini M; Reis SR; Torrentes-Carvalho A; Azeredo EL; Freire Mda S; Galler R; Kubelka CF Mem Inst Oswaldo Cruz; 2011 Aug; 106(5):594-605. PubMed ID: 21894381 [TBL] [Abstract][Full Text] [Related]
7. Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine. Liang H; Lee M; Jin X Cell Mol Immunol; 2016 Jan; 13(1):36-46. PubMed ID: 26435066 [TBL] [Abstract][Full Text] [Related]
9. Dengue in travellers is still underestimated. Allwinn R; Hofknecht N; Doerr HW Intervirology; 2008; 51(2):96-100. PubMed ID: 18477850 [TBL] [Abstract][Full Text] [Related]
10. Dengue fever and dengue haemorrhagic fever--a diagnostic challenge. Senanayake S Aust Fam Physician; 2006 Aug; 35(8):609-12. PubMed ID: 16894436 [TBL] [Abstract][Full Text] [Related]
11. Dengue haemorrhagic fever/dengue shock syndrome. An unwelcome arrival in Trinidad. Teelucksingh S; Mangray AS; Barrow S; Jankey N; Prabhakar P; Lewis M West Indian Med J; 1997 Jun; 46(2):38-42. PubMed ID: 9260532 [TBL] [Abstract][Full Text] [Related]
12. Answer to the review from Halstead and Russell "Protective and immunological behavior of chimeric yellow fever dengue vaccine" (DOI 10.1016/j.vaccine.2016.02.004). Hadinegoro SR; Arredondo-García JL; Guy B; Bouckenooghe A; Noriega F; Jackson N Vaccine; 2016 Aug; 34(36):4273-4. PubMed ID: 27452651 [No Abstract] [Full Text] [Related]
13. Clinical features and laboratory findings of dengue fever in German travellers: A single-centre, retrospective analysis. Tavakolipoor P; Schmidt-Chanasit J; Burchard GD; Jordan S Travel Med Infect Dis; 2016; 14(1):39-44. PubMed ID: 26876059 [TBL] [Abstract][Full Text] [Related]
14. International travel between global urban centres vulnerable to yellow fever transmission. Brent SE; Watts A; Cetron M; German M; Kraemer MU; Bogoch II; Brady OJ; Hay SI; Creatore MI; Khan K Bull World Health Organ; 2018 May; 96(5):343-354B. PubMed ID: 29875519 [TBL] [Abstract][Full Text] [Related]
16. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. Johnson BW; Kosoy O; Martin DA; Noga AJ; Russell BJ; Johnson AA; Petersen LR Vector Borne Zoonotic Dis; 2005; 5(2):137-45. PubMed ID: 16011430 [TBL] [Abstract][Full Text] [Related]
17. Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses. Silva JVJ; Lopes TRR; Oliveira-Filho EF; Oliveira RAS; Durães-Carvalho R; Gil LHVG Acta Trop; 2018 Jun; 182():257-263. PubMed ID: 29551394 [TBL] [Abstract][Full Text] [Related]
18. [Reflection on 2 current viral diseases: yellow fever and dengue]. Chastel C Ann Biol Clin (Paris); 1997; 55(5):415-24. PubMed ID: 9347008 [TBL] [Abstract][Full Text] [Related]
19. Dengue Virus Seroconversion in Travelers to Dengue-Endemic Areas. Olivero RM; Hamer DH; MacLeod WB; Benoit CM; Sanchez-Vegas C; Jentes ES; Chen LH; Wilson ME; Marano N; Yanni EA; Ooi WW; Karchmer AW; Kogelman L; Barnett ED Am J Trop Med Hyg; 2016 Nov; 95(5):1130-1136. PubMed ID: 27573631 [TBL] [Abstract][Full Text] [Related]
20. Preliminary study of dengue virus infection in Iran. Chinikar S; Ghiasi SM; Shah-Hosseini N; Mostafavi E; Moradi M; Khakifirouz S; Rasi Varai FS; Rafigh M; Jalali T; Goya MM; Shirzadi MR; Zainali M; Fooks AR Travel Med Infect Dis; 2013; 11(3):166-9. PubMed ID: 23194952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]